CAR-T CD19 cell therapy (mRNA technology, Non-Hodgkin’s Lymphoma)

Plerixafor(Mozobil, Plerixafor Accord)

C₂₈H₅₄N₈ · Rx

Non-Hodgkin's lymphoma vaccine(CellGenix GmbH)

Non-Hodgkin's lymphoma vaccine (XEME Biopharma)

anti-CD22 degrader-antibody conjugates (non-Hodgkin lymphoma/NSCLC)

allogeneic CD19-STAR-T cell therapy (B-cell Non-Hodgkin's Lymphoma)

anti-CD19 CAR T-cell therapy (B-cell Non-Hodgkin's Lymphoma)

anti-CD19 CAR T-cell therapy (B-cell non-Hodgkin lymphoma)

dual anti-CD19 CAR T-cell therapy/PD-1 checkpoint inhibitor (non-Hodgkin lymphoma/B-cell lymphoma)